Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD | Market Cap | 335.69M |
| Revenue (ttm) | 367.13M |
| Net Income (ttm) | -57.26M |
| Shares Out | 56.70M |
| EPS (ttm) | -1.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 409,707 |
| Average Volume | 906,846 |
| Open | 5.94 |
| Previous Close | 5.92 |
| Day's Range | 5.86 - 5.94 |
| 52-Week Range | 4.95 - 9.90 |
| Beta | 1.24 |
| RSI | 41.57 |
| Earnings Date | Feb 5, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, c... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Should You Buy ACB Stock After Marijuana Reclassification Order?
Aurora Cannabis faces uneven gains from marijuana reclassification as medical cannabis drives growth, while weak consumer sales affect optimism.
Best Canadian Cannabis Stocks to Watch Entering 2026
The cannabis industry continues to evolve as investors look toward 2026 with renewed optimism. Canadian cannabis companies remain at the center of global expansion. They benefit from strong medical pr...
Trump Is Warming to Cannabis, but Investors Aren't Impressed
Stocks took a surprise tumble after the White House moved to reclassify marijuana as a less dangerous drug.
Do These 2 Cannabis Stocks Have a Future?
Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention...
2 Marijuana Stocks To Watch For Better Investing In 2026
The cannabis industry continues evolving into a bigger and more regulated global market. Legalization trends are expanding across the United States and international regions. This growth fuels long-te...
I Was Right: President Trump Will Legalize Marijuana in 2026
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come.
3 Marijuana Stocks To Watch In 2026
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. Af...
Marijuana Stocks To Watch After The Holidays
In 2026, the impact of cannabis rescheduling is expected to be far more visible in marijuana stock performance. Much more than in the initial announcement of cannabis becoming a Class 3 substance. Whi...
Trump Pushes for Swift Reevaluation of Marijuana Laws Impacting Aurora Cannabis (ACB)
Trump Pushes for Swift Reevaluation of Marijuana Laws Impacting Aurora Cannabis (ACB)
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling...
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff ...
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe...
After Trump's move to reclassify cannabis, here's what Wall Street is thinking
Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities.
Trump signs executive order to reschedule cannabis. Here's what's next
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal gov...
Trump sparks market shock with MAJOR marijuana move
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's...
Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing
Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to recla...
Why US banks are still wary of cannabis despite Trump's policy shift
President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream ...
How Trump's marijuana reclassification could impact medical research
Scotts Miracle-Gro CEO James Hagedorn discusses President Donald Trump signing an executive order to reclassify marijuana on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #brea...
Cannabis companies face hurdles accessing big banks despite reclassification, experts say
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Trulieve CEO Kim Rivers reacts to marijuana being reclassified
Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.
Trump signed an executive order to reclassify marijuana.
About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage ...
Trump signs order to expedite marijuana reschedules, Kevin Hassett vs. Kevin Warsh in Fed chair race
Market Domination Overtime anchor Josh Lipton breaks down the latest market moves for December 18, 2025. President Trump signed an executive order today to expedite the rescheduling of marijuana.
Aurora Cannabis (ACB) Sees Potential Boost from New Cannabis Reclassification Efforts
Aurora Cannabis (ACB) Sees Potential Boost from New Cannabis Reclassification Efforts